Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
An Open-labeled, Randomized, Parallel Group Trial of zalutumumab, a Human Monoclonal Anti-EGF receptor Antibody, in combination with Best Supportive Care, versus Best Supportive Care, in Patients with Non-Curable Squamous Cell Carcinoma of the Head and Neck who have failed standard platinum-based chemotherapy https://kusajili.fr:443/Trial/5xsOJokzrk6Kaf65ae_VFg%24an-open-labeled-randomized-parallel-group-trial-of-zalutumumab-a-human-monoclonal-anti-egf-receptor-antibody-in-combination-wit
I have read and accept the terms of use of the site and the Privacy Policy
Send your message